These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30649734)

  • 1. Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records.
    Liu F; Jagannatha A; Yu H
    Drug Saf; 2019 Jan; 42(1):95-97. PubMed ID: 30649734
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of Adverse Events in Colombia: A Successful Case.
    Moreno-Mattar O; Ramírez R; Alvarado A; Sierra F; Guzmán J
    Curr Drug Saf; 2019; 14(1):53-56. PubMed ID: 30411692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacovigilance - The next chapter.
    Moore N; Berdaï D; Blin P; Droz C
    Therapie; 2019 Dec; 74(6):557-567. PubMed ID: 31623850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fifty years of pharmacovigilance - Medicines safety and public health.
    Laporte JR
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):725-32. PubMed ID: 26799344
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study.
    de Bie S; Coloma PM; Ferrajolo C; Verhamme KM; Trifirò G; Schuemie MJ; Straus SM; Gini R; Herings R; Mazzaglia G; Picelli G; Ghirardi A; Pedersen L; Stricker BH; van der Lei J; Sturkenboom MC;
    Br J Clin Pharmacol; 2015 Aug; 80(2):304-14. PubMed ID: 25683723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting Adverse Drug Events with Rapidly Trained Classification Models.
    Chapman AB; Peterson KS; Alba PR; DuVall SL; Patterson OV
    Drug Saf; 2019 Jan; 42(1):147-156. PubMed ID: 30649737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward enhanced pharmacovigilance using patient-generated data on the internet.
    White RW; Harpaz R; Shah NH; DuMouchel W; Horvitz E
    Clin Pharmacol Ther; 2014 Aug; 96(2):239-46. PubMed ID: 24713590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres.
    Kant A; de Vries L; Rolfes L
    Drug Saf; 2019 Jan; 42(1):35-43. PubMed ID: 30284215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.
    Luo Y; Thompson WK; Herr TM; Zeng Z; Berendsen MA; Jonnalagadda SR; Carson MB; Starren J
    Drug Saf; 2017 Nov; 40(11):1075-1089. PubMed ID: 28643174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in pharmacovigilance: value and gaps of patient reporting.
    Inácio P; Cavaco A; Airaksinen M
    Int J Clin Pharm; 2018 Aug; 40(4):754-757. PubMed ID: 30006734
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacovigilance Programme of India: Recent developments and future perspectives.
    Kalaiselvan V; Thota P; Singh GN
    Indian J Pharmacol; 2016; 48(6):624-628. PubMed ID: 28066097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The class imbalance problem detecting adverse drug reactions in electronic health records.
    Santiso S; Casillas A; Pérez A
    Health Informatics J; 2019 Dec; 25(4):1768-1778. PubMed ID: 30230408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes.
    Yang X; Bian J; Gong Y; Hogan WR; Wu Y
    Drug Saf; 2019 Jan; 42(1):123-133. PubMed ID: 30600484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of natural language processing for classification tasks in the field of incident reporting and adverse event analysis.
    Young IJB; Luz S; Lone N
    Int J Med Inform; 2019 Dec; 132():103971. PubMed ID: 31630063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of internet search logs to evaluate potential drug adverse events.
    Sarntivijai S; Abernethy DR
    Clin Pharmacol Ther; 2014 Aug; 96(2):149-50. PubMed ID: 25056395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor's Perspective.
    Beyzarov E; Chen Y; Julg R; Naim K; Shah J; Gregory WW; Ayoub A; Caubel P
    Drug Saf; 2021 Jan; 44(1):95-105. PubMed ID: 33354753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting adverse drug reactions in discharge summaries of electronic medical records using Readpeer.
    Tang Y; Yang J; Ang PS; Dorajoo SR; Foo B; Soh S; Tan SH; Tham MY; Ye Q; Shek L; Sung C; Tung A
    Int J Med Inform; 2019 Aug; 128():62-70. PubMed ID: 31160013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional Study.
    Akbarov A; Kontopantelis E; Sperrin M; Stocks SJ; Williams R; Rodgers S; Avery A; Buchan I; Ashcroft DM
    Drug Saf; 2015 Jul; 38(7):671-82. PubMed ID: 26100143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance using clinical notes.
    LePendu P; Iyer SV; Bauer-Mehren A; Harpaz R; Mortensen JM; Podchiyska T; Ferris TA; Shah NH
    Clin Pharmacol Ther; 2013 Jun; 93(6):547-55. PubMed ID: 23571773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.